sales@marketresearchvision.com

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports


Global COPD Drugs Market Size, Status and Forecast 2020-2026

Global COPD Drugs Market Size, Status and Forecast 2020-2026

Category : Pharmaceuticals and Healthcare QY Research Pages :91
Published Date : 2020-11-17

 

Covid-19

COVID-19

Understand the influence of COVID-19 on the COPD Drugs Market with our analysts monitoring the situation across the globe.
COPD Drugs market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global COPD Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026. The key players covered in this study Pfizer Novartis GlaxoSmithKline Merck Abbott Laboratories Boehringer Ingelheim AstraZeneca Roche Holding AG Teva Pharmaceutical Industries Vectura Group Mylan NV Market segment by Type, the product can be split into Bronchodilators PDE-4 Inhibitors Steroids Combination Therapies Others Market segment by Application, split into Hospitals Clinics Others Market segment by Regions/Countries, this report covers North America Europe China Japan Southeast Asia India Central & South America
1 Report Overview 1.1 Study Scope 1.2 Key Market Segments 1.3 Players Covered: Ranking by COPD Drugs Revenue 1.4 Market by Type 1.4.1 Global COPD Drugs Market Size Growth Rate by Type: 2020 VS 2026 1.4.2 Bronchodilators 1.4.3 PDE-4 Inhibitors 1.4.4 Steroids 1.4.5 Combination Therapies 1.4.6 Others 1.5 Market by Application 1.5.1 Global COPD Drugs Market Share by Application: 2020 VS 2026 1.5.2 Hospitals 1.5.3 Clinics 1.5.4 Others 1.6 Study Objectives 1.7 Years Considered 2 Global Growth Trends 2.1 Global COPD Drugs Market Perspective (2015-2026) 2.2 Global COPD Drugs Growth Trends by Regions 2.2.1 COPD Drugs Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 COPD Drugs Historic Market Share by Regions (2015-2020) 2.2.3 COPD Drugs Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Top Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Porter’s Five Forces Analysis 2.3.5 COPD Drugs Market Growth Strategy 2.3.6 Primary Interviews with Key COPD Drugs Players (Opinion Leaders) 3 Competition Landscape by Key Players 3.1 Global Top COPD Drugs Players by Market Size 3.1.1 Global Top COPD Drugs Players by Revenue (2015-2020) 3.1.2 Global COPD Drugs Revenue Market Share by Players (2015-2020) 3.1.3 Global COPD Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.2 Global COPD Drugs Market Concentration Ratio 3.2.1 Global COPD Drugs Market Concentration Ratio (CR5 and HHI) 3.2.2 Global Top 10 and Top 5 Companies by COPD Drugs Revenue in 2019 3.3 COPD Drugs Key Players Head office and Area Served 3.4 Key Players COPD Drugs Product Solution and Service 3.5 Date of Enter into COPD Drugs Market 3.6 Mergers & Acquisitions, Expansion Plans 4 Market Size by Type (2015-2026) 4.1 Global COPD Drugs Historic Market Size by Type (2015-2020) 4.2 Global COPD Drugs Forecasted Market Size by Type (2021-2026) 5 Market Size by Application (2015-2026) 5.1 Global COPD Drugs Market Size by Application (2015-2020) 5.2 Global COPD Drugs Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America COPD Drugs Market Size (2015-2020) 6.2 COPD Drugs Key Players in North America (2019-2020) 6.3 North America COPD Drugs Market Size by Type (2015-2020) 6.4 North America COPD Drugs Market Size by Application (2015-2020) 7 Europe 7.1 Europe COPD Drugs Market Size (2015-2020) 7.2 COPD Drugs Key Players in Europe (2019-2020) 7.3 Europe COPD Drugs Market Size by Type (2015-2020) 7.4 Europe COPD Drugs Market Size by Application (2015-2020) 8 China 8.1 China COPD Drugs Market Size (2015-2020) 8.2 COPD Drugs Key Players in China (2019-2020) 8.3 China COPD Drugs Market Size by Type (2015-2020) 8.4 China COPD Drugs Market Size by Application (2015-2020) 9 Japan 9.1 Japan COPD Drugs Market Size (2015-2020) 9.2 COPD Drugs Key Players in Japan (2019-2020) 9.3 Japan COPD Drugs Market Size by Type (2015-2020) 9.4 Japan COPD Drugs Market Size by Application (2015-2020) 10 Southeast Asia 10.1 Southeast Asia COPD Drugs Market Size (2015-2020) 10.2 COPD Drugs Key Players in Southeast Asia (2019-2020) 10.3 Southeast Asia COPD Drugs Market Size by Type (2015-2020) 10.4 Southeast Asia COPD Drugs Market Size by Application (2015-2020) 11 India 11.1 India COPD Drugs Market Size (2015-2020) 11.2 COPD Drugs Key Players in India (2019-2020) 11.3 India COPD Drugs Market Size by Type (2015-2020) 11.4 India COPD Drugs Market Size by Application (2015-2020) 12 Central & South America 12.1 Central & South America COPD Drugs Market Size (2015-2020) 12.2 COPD Drugs Key Players in Central & South America (2019-2020) 12.3 Central & South America COPD Drugs Market Size by Type (2015-2020) 12.4 Central & South America COPD Drugs Market Size by Application (2015-2020) 13 Key Players Profiles 13.1 Pfizer 13.1.1 Pfizer Company Details 13.1.2 Pfizer Business Overview 13.1.3 Pfizer COPD Drugs Introduction 13.1.4 Pfizer Revenue in COPD Drugs Business (2015-2020)) 13.1.5 Pfizer Recent Development 13.2 Novartis 13.2.1 Novartis Company Details 13.2.2 Novartis Business Overview 13.2.3 Novartis COPD Drugs Introduction 13.2.4 Novartis Revenue in COPD Drugs Business (2015-2020) 13.2.5 Novartis Recent Development 13.3 GlaxoSmithKline 13.3.1 GlaxoSmithKline Company Details 13.3.2 GlaxoSmithKline Business Overview 13.3.3 GlaxoSmithKline COPD Drugs Introduction 13.3.4 GlaxoSmithKline Revenue in COPD Drugs Business (2015-2020) 13.3.5 GlaxoSmithKline Recent Development 13.4 Merck 13.4.1 Merck Company Details 13.4.2 Merck Business Overview 13.4.3 Merck COPD Drugs Introduction 13.4.4 Merck Revenue in COPD Drugs Business (2015-2020) 13.4.5 Merck Recent Development 13.5 Abbott Laboratories 13.5.1 Abbott Laboratories Company Details 13.5.2 Abbott Laboratories Business Overview 13.5.3 Abbott Laboratories COPD Drugs Introduction 13.5.4 Abbott Laboratories Revenue in COPD Drugs Business (2015-2020) 13.5.5 Abbott Laboratories Recent Development 13.6 Boehringer Ingelheim 13.6.1 Boehringer Ingelheim Company Details 13.6.2 Boehringer Ingelheim Business Overview 13.6.3 Boehringer Ingelheim COPD Drugs Introduction 13.6.4 Boehringer Ingelheim Revenue in COPD Drugs Business (2015-2020) 13.6.5 Boehringer Ingelheim Recent Development 13.7 AstraZeneca 13.7.1 AstraZeneca Company Details 13.7.2 AstraZeneca Business Overview 13.7.3 AstraZeneca COPD Drugs Introduction 13.7.4 AstraZeneca Revenue in COPD Drugs Business (2015-2020) 13.7.5 AstraZeneca Recent Development 13.8 Roche Holding AG 13.8.1 Roche Holding AG Company Details 13.8.2 Roche Holding AG Business Overview 13.8.3 Roche Holding AG COPD Drugs Introduction 13.8.4 Roche Holding AG Revenue in COPD Drugs Business (2015-2020) 13.8.5 Roche Holding AG Recent Development 13.9 Teva Pharmaceutical Industries 13.9.1 Teva Pharmaceutical Industries Company Details 13.9.2 Teva Pharmaceutical Industries Business Overview 13.9.3 Teva Pharmaceutical Industries COPD Drugs Introduction 13.9.4 Teva Pharmaceutical Industries Revenue in COPD Drugs Business (2015-2020) 13.9.5 Teva Pharmaceutical Industries Recent Development 13.10 Vectura Group 13.10.1 Vectura Group Company Details 13.10.2 Vectura Group Business Overview 13.10.3 Vectura Group COPD Drugs Introduction 13.10.4 Vectura Group Revenue in COPD Drugs Business (2015-2020) 13.10.5 Vectura Group Recent Development 13.11 Mylan NV 10.11.1 Mylan NV Company Details 10.11.2 Mylan NV Business Overview 10.11.3 Mylan NV COPD Drugs Introduction 10.11.4 Mylan NV Revenue in COPD Drugs Business (2015-2020) 10.11.5 Mylan NV Recent Development 14 Analyst's Viewpoints/Conclusions 15 Appendix 15.1 Research Methodology 15.1.1 Methodology/Research Approach 15.1.2 Data Source 15.2 Disclaimer 15.3 Author Details

Get Free Sample

List of Tables Table 1. COPD Drugs Key Market Segments Table 2. Key Players Covered: Ranking by COPD Drugs Revenue Table 3. Ranking of Global Top COPD Drugs Manufacturers by Revenue (US$ Million) in 2019 Table 4. Global COPD Drugs Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 5. Key Players of Bronchodilators Table 6. Key Players of PDE-4 Inhibitors Table 7. Key Players of Steroids Table 8. Key Players of Combination Therapies Table 9. Key Players of Others Table 10. Global COPD Drugs Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 11. Global COPD Drugs Market Size by Regions (US$ Million): 2020 VS 2026 Table 12. Global COPD Drugs Market Size by Regions (2015-2020) (US$ Million) Table 13. Global COPD Drugs Market Share by Regions (2015-2020) Table 14. Global COPD Drugs Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 15. Global COPD Drugs Market Share by Regions (2021-2026) Table 16. Market Top Trends Table 17. Key Drivers: Impact Analysis Table 18. Key Challenges Table 19. COPD Drugs Market Growth Strategy Table 20. Main Points Interviewed from Key COPD Drugs Players Table 21. Global COPD Drugs Revenue by Players (2015-2020) (Million US$) Table 22. Global COPD Drugs Market Share by Players (2015-2020) Table 23. Global Top COPD Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Drugs as of 2019) Table 24. Global COPD Drugs by Players Market Concentration Ratio (CR5 and HHI) Table 25. Key Players Headquarters and Area Served Table 26. Key Players COPD Drugs Product Solution and Service Table 27. Date of Enter into COPD Drugs Market Table 28. Mergers & Acquisitions, Expansion Plans Table 29. Global COPD Drugs Market Size by Type (2015-2020) (Million US$) Table 30. Global COPD Drugs Market Size Share by Type (2015-2020) Table 31. Global COPD Drugs Revenue Market Share by Type (2021-2026) Table 32. Global COPD Drugs Market Size Share by Application (2015-2020) Table 33. Global COPD Drugs Market Size by Application (2015-2020) (Million US$) Table 34. Global COPD Drugs Market Size Share by Application (2021-2026) Table 35. North America Key Players COPD Drugs Revenue (2019-2020) (Million US$) Table 36. North America Key Players COPD Drugs Market Share (2019-2020) Table 37. North America COPD Drugs Market Size by Type (2015-2020) (Million US$) Table 38. North America COPD Drugs Market Share by Type (2015-2020) Table 39. North America COPD Drugs Market Size by Application (2015-2020) (Million US$) Table 40. North America COPD Drugs Market Share by Application (2015-2020) Table 41. Europe Key Players COPD Drugs Revenue (2019-2020) (Million US$) Table 42. Europe Key Players COPD Drugs Market Share (2019-2020) Table 43. Europe COPD Drugs Market Size by Type (2015-2020) (Million US$) Table 44. Europe COPD Drugs Market Share by Type (2015-2020) Table 45. Europe COPD Drugs Market Size by Application (2015-2020) (Million US$) Table 46. Europe COPD Drugs Market Share by Application (2015-2020) Table 47. China Key Players COPD Drugs Revenue (2019-2020) (Million US$) Table 48. China Key Players COPD Drugs Market Share (2019-2020) Table 49. China COPD Drugs Market Size by Type (2015-2020) (Million US$) Table 50. China COPD Drugs Market Share by Type (2015-2020) Table 51. China COPD Drugs Market Size by Application (2015-2020) (Million US$) Table 52. China COPD Drugs Market Share by Application (2015-2020) Table 53. Japan Key Players COPD Drugs Revenue (2019-2020) (Million US$) Table 54. Japan Key Players COPD Drugs Market Share (2019-2020) Table 55. Japan COPD Drugs Market Size by Type (2015-2020) (Million US$) Table 56. Japan COPD Drugs Market Share by Type (2015-2020) Table 57. Japan COPD Drugs Market Size by Application (2015-2020) (Million US$) Table 58. Japan COPD Drugs Market Share by Application (2015-2020) Table 59. Southeast Asia Key Players COPD Drugs Revenue (2019-2020) (Million US$) Table 60. Southeast Asia Key Players COPD Drugs Market Share (2019-2020) Table 61. Southeast Asia COPD Drugs Market Size by Type (2015-2020) (Million US$) Table 62. Southeast Asia COPD Drugs Market Share by Type (2015-2020) Table 63. Southeast Asia COPD Drugs Market Size by Application (2015-2020) (Million US$) Table 64. Southeast Asia COPD Drugs Market Share by Application (2015-2020) Table 65. India Key Players COPD Drugs Revenue (2019-2020) (Million US$) Table 66. India Key Players COPD Drugs Market Share (2019-2020) Table 67. India COPD Drugs Market Size by Type (2015-2020) (Million US$) Table 68. India COPD Drugs Market Share by Type (2015-2020) Table 69. India COPD Drugs Market Size by Application (2015-2020) (Million US$) Table 70. India COPD Drugs Market Share by Application (2015-2020) Table 71. Central & South America Key Players COPD Drugs Revenue (2019-2020) (Million US$) Table 72. Central & South America Key Players COPD Drugs Market Share (2019-2020) Table 73. Central & South America COPD Drugs Market Size by Type (2015-2020) (Million US$) Table 74. Central & South America COPD Drugs Market Share by Type (2015-2020) Table 75. Central & South America COPD Drugs Market Size by Application (2015-2020) (Million US$) Table 76. Central & South America COPD Drugs Market Share by Application (2015-2020) Table 77. Pfizer Company Details Table 78. Pfizer Business Overview Table 79. Pfizer Product Table 80. Pfizer Revenue in COPD Drugs Business (2015-2020) (Million US$) Table 81. Pfizer Recent Development Table 82. Novartis Company Details Table 83. Novartis Business Overview Table 84. Novartis Product Table 85. Novartis Revenue in COPD Drugs Business (2015-2020) (Million US$) Table 86. Novartis Recent Development Table 87. GlaxoSmithKline Company Details Table 88. GlaxoSmithKline Business Overview Table 89. GlaxoSmithKline Product Table 90. GlaxoSmithKline Revenue in COPD Drugs Business (2015-2020) (Million US$) Table 91. GlaxoSmithKline Recent Development Table 92. Merck Company Details Table 93. Merck Business Overview Table 94. Merck Product Table 95. Merck Revenue in COPD Drugs Business (2015-2020) (Million US$) Table 96. Merck Recent Development Table 97. Abbott Laboratories Company Details Table 98. Abbott Laboratories Business Overview Table 99. Abbott Laboratories Product Table 100. Abbott Laboratories Revenue in COPD Drugs Business (2015-2020) (Million US$) Table 101. Abbott Laboratories Recent Development Table 102. Boehringer Ingelheim Company Details Table 103. Boehringer Ingelheim Business Overview Table 104. Boehringer Ingelheim Product Table 105. Boehringer Ingelheim Revenue in COPD Drugs Business (2015-2020) (Million US$) Table 106. Boehringer Ingelheim Recent Development Table 107. AstraZeneca Company Details Table 108. AstraZeneca Business Overview Table 109. AstraZeneca Product Table 110. AstraZeneca Revenue in COPD Drugs Business (2015-2020) (Million US$) Table 111. AstraZeneca Recent Development Table 112. Roche Holding AG Business Overview Table 113. Roche Holding AG Product Table 114. Roche Holding AG Company Details Table 115. Roche Holding AG Revenue in COPD Drugs Business (2015-2020) (Million US$) Table 116. Roche Holding AG Recent Development Table 117. Teva Pharmaceutical Industries Company Details Table 118. Teva Pharmaceutical Industries Business Overview Table 119. Teva Pharmaceutical Industries Product Table 120. Teva Pharmaceutical Industries Revenue in COPD Drugs Business (2015-2020) (Million US$) Table 121. Teva Pharmaceutical Industries Recent Development Table 122. Vectura Group Company Details Table 123. Vectura Group Business Overview Table 124. Vectura Group Product Table 125. Vectura Group Revenue in COPD Drugs Business (2015-2020) (Million US$) Table 126. Vectura Group Recent Development Table 127. Mylan NV Company Details Table 128. Mylan NV Business Overview Table 129. Mylan NV Product Table 130. Mylan NV Revenue in COPD Drugs Business (2015-2020) (Million US$) Table 131. Mylan NV Recent Development Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Global COPD Drugs Market Share by Type: 2020 VS 2026 Figure 2. Bronchodilators Features Figure 3. PDE-4 Inhibitors Features Figure 4. Steroids Features Figure 5. Combination Therapies Features Figure 6. Others Features Figure 7. Global COPD Drugs Market Share by Application: 2020 VS 2026 Figure 8. Hospitals Case Studies Figure 9. Clinics Case Studies Figure 10. Others Case Studies Figure 11. COPD Drugs Report Years Considered Figure 12. Global COPD Drugs Market Size YoY Growth 2015-2026 (US$ Million) Figure 13. Global COPD Drugs Market Share by Regions: 2020 VS 2026 Figure 14. Global COPD Drugs Market Share by Regions (2021-2026) Figure 15. Porter's Five Forces Analysis Figure 16. Global COPD Drugs Market Share by Players in 2019 Figure 17. Global Top COPD Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Drugs as of 2019 Figure 18. The Top 10 and 5 Players Market Share by COPD Drugs Revenue in 2019 Figure 19. North America COPD Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 20. Europe COPD Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 21. China COPD Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 22. Japan COPD Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 23. Southeast Asia COPD Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 24. India COPD Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 25. Central & South America COPD Drugs Market Size YoY Growth (2015-2020) (Million US$) Figure 26. Bottom-up and Top-down Approaches for This Report Figure 27. Data Triangulation Figure 28. Key Executives Interviewed

Get Free Sample

Related Reports

Global COPD Drugs Market Size, Status and Forecast 2020-2026

Global Cushing's Syndrome Treatment Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most ...
read more

Global COPD Drugs Market Size, Status and Forecast 2020-2026

Global Tyrosine Kinase Inhibitors Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Tyrosine kinase inhibitors are small molecules that bind to the receptor site of the kinase enzyme available at cell surface. Scope of the Report: The global tyrosine kinase inhibitors market is e ...
read more

Global COPD Drugs Market Size, Status and Forecast 2020-2026

Global 2D Chromatography Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

2D chromatography is a type of chromatographic technique in which the injected sample is separated by passing through two different separation stages. This is done by injecting the eluent from the fir ...
read more

Global COPD Drugs Market Size, Status and Forecast 2020-2026

Global Astringent Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Astringent are used as an adjunct or alternative to standard suturing techniques to control bleeding or for wound closure. Scope of the Report: In 2018, North America is expected to account for th ...
read more

Global COPD Drugs Market Size, Status and Forecast 2020-2026

Global Disintegrants Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Disintegrants are agents added to tablet (and some encapsulated) formulations to promote the breakup of the tablet (and capsule “slugs') into smaller fragments in an aqueous environment thereby ...
read more


Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.


Cards For Payment

Why Choose us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
-Marketing Manager at a pharma company in Belgium

How To Reach Us

Reach out to our most senior Sales Professional-
Jay Matthews

+1 513 549 5911 (U.S.),
    +44 203 318 2846 (U.K.)
sales@marketresearchvision.com
 

Our Clients






Market Research Vision

About Us


Market Research Vision is a leading market research and market intelligence organization, specializing in research, analytics, and advisory services along with providing business insights & market research reports. Serving as a market research firm, we help our clients in finding: what’s next? We believe in finding creative and innovative solutions through customized and syndicated research reports.
Read More


Contact Us


 
sales@marketresearchvision.com


+1 513 549 5911 (U.S.)
+44 203 318 2846 (U.K.)